Leukocyte Ig-Like Receptor B2/LILRB2/ILT4/CD85d (C-Avi-6His) Biotinylated (recombinant human)

Leukocyte Ig-Like Receptor B2/LILRB2/ILT4/CD85d (C-Avi-6His) Biotinylated (recombinant human)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
E-PKSH033919.20 20 µg -

7 - 16 business days*

406.00€
E-PKSH033919.100 100 µg -

7 - 16 business days*

1,097.00€
 
Protein Construction: Recombinant Human Leukocyte Immunoglobulin-Like Receptor Subfamily B Member... more
Product information "Leukocyte Ig-Like Receptor B2/LILRB2/ILT4/CD85d (C-Avi-6His) Biotinylated (recombinant human)"
Protein Construction: Recombinant Human Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2 is produced by our Mammalian expression system and the target gene encoding Gln22-His458 is expressed with a Avi, 6His tag at the C-terminus. Sequence: Gln22-His458. Fusion tag: C-Avi-6His Endotoxin: < 1.0 EU per µg as determined by the LAL method. Apparent Molecular Mass: 60-80 kDa. Protein function: Members of the immunoglobulin-like transcript (ILT) family are activating and inhibitory immunoreceptors whose genes are located same locus that encodes killer cell Ig-like receptors (KIR). Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2 (LIR-2) is a type I transmembrane protein. LIR-2 is expressed primarily on monocytes and dendritic cells (DC). Human LIR-2 is produced as a 598 amino acino acid precursor including a 21 aa signal sequence, a 440 aa extracellular domain (ECD), a 21 aa transmenbrane segment, and a 116 aa cytoplasmic domain. LIR-2 binds to Classical MHCI proteins. Ligation of LIR-2 incluces Tyr phosphorylation within its cytoplasmic ITIMs, a requirement for association with SHP-1. LIR-2 mediates tolerogenic DC-induced CD4+ T cell energy in vitro and in vivo. Protein function: Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles (PubMed:11169396, PubMed:12853576, PubMed:16455647, PubMed:20448110, PubMed:27859042). Involved in the down-regulation of the immune response and the development of tolerance. Recognizes HLA-G in complex with B2M/beta-2 microglobulin and a nonamer self-peptide (peptide-bound HLA-G-B2M) triggering differentiation of type 1 regulatory T cells and myeloid-derived suppressor cells, both of which actively maintain maternal-fetal tolerance (PubMed:20448110, PubMed:27859042, PubMed:16455647). Competes with CD8A for binding to class I MHC antigens. Inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions (PubMed:11875462, PubMed:12853576, PubMed:9548455, PubMed:9842885). [The UniProt Consortium]
Keywords: ILT-4, CD85d, LIR-2, MIR-10, Immunoglobulin-like transcript 4, CD85 antigen-like family member D, Leukocyte immunoglobulin-like receptor 2, Monocyte/macrophage immunoglobulin-like receptor 10, Leukocyte immunoglobulin-like receptor subfamily B member 2, R
Supplier: Elabscience
Supplier-Nr: E-PKSH033919

Properties

Conjugate: Biotin
Host: Human cells
Species reactivity: human
MW: 50.2 kD
Format: Lyophilized

Database Information

KEGG ID : K06512 | Matching products
UniProt ID : Q8N423 | Matching products

Handling & Safety

Storage: -80°C
Shipping: 4°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Leukocyte Ig-Like Receptor B2/LILRB2/ILT4/CD85d (C-Avi-6His) Biotinylated (recombinant human)"
Write a review
or to review a product.
Viewed